Eckert & Ziegler Strahlen- und Medizintechnik AG Financials

Market Capitalization €980.2 Million as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	27.13
Forward PE	23.83
Price to Sales TTM	€3.58
Price to Book MRQ	€4.40
Enterprise to Revenue	3.00
Enterprise to EBITDA	12.32

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	12.22%
Operating Margin	21.80%
Return on Assets TTM	7.70%
Return on Equity TTM	16.68%

Income Statement

Revenue TTM	€273,512,000
Revenue per Share TTM	€13.13
Quarterly Revenue Growth	29.50%
Gross Profit TTM	€131,878,000
EBITDA	€75,903,000
Net Income to Common TTM	€37,721,000
Diluted EPS TTM	€1.73
Quarterly Earnings Growth YoY	54.70%

Balance Sheet

Total Cash MRQ	€76,625,000
Total Cash per Share MRQ	€3.68
Total Debt MRQ	€
Total Debt to Equity MRQ	21.96
Current Ratio MRQ	2.91
Book Value per Share MRQ	€10.67

Cash Flow

Operating Cash Flow TTM	€36,379,000
Levered Free Cash Flow TTM	€-41,017,752

EUZ Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	20,845,500
Float Shares	13,617,308
Avg 10 Volume	324
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	31.38%
% Held by Institutions	22.18%

Stock Price Summary

Beta	1.33
Fifty Two Week Low	€32.50
Fifty Two Week High	€53.15
Fifty Two Week Change	12.14%
Day 50 MA	€43.80
Day 200 MA	€42.83

Dividends and Splits

Forward Annual Dividend Rate	€0.20
Forward Annual Dividend Yield	0.38%
Trailing Annual Dividend Rate	€0.05
Trailing Annual Dividend Yield	0.09%
Payout Ratio	2.73%
Dividend Date
Ex Dividend Date	2024-06-27
Last Split Factor
Last Split Date	2020-07-31